Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial - Concepedia

Concepedia

Publication | Closed Access

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

491

Citations

0

References

2006

Year

Volker Schächinger, Sandra Erbs, A. Elsasser, Werner Haberbosch, Rainer Hambrecht, Hans Hölschermann, J. Yu, Roberto Corti, Detlef G. Mathey, C Hamm,

European Heart Journal

Abstract

Intracoronary administration of BMCs is associated with a significant reduction of the occurrence of major adverse cardiovascular events after AMI. Large-scale studies are warranted to confirm the effects of BMC administration on mortality and morbidity in patients with AMIs.